Search
for
Sort by
Research 29
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Structural & functional studies of L-PGDS and SMPDL3A enzymes in lipid signaling family
- Genetic and molecular aspects of androgenetic alopecia
- Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase
- Biochemical and Structural Characteristics, Gene Regulation, Physiological, Pathological and Clinical Features of Lipocalin-Type Prostaglandin D2 Synthase as a Multifunctional Lipocalin
- High-resolution structures of mutants of residues that affect access to the ligand-binding cavity of human lipocalin-type prostaglandin D synthase
- Does prostaglandin D<sub>2</sub> hold the cure to male pattern baldness?
- Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study
- Prostaglandin D2 Inhibits Wound-Induced Hair Follicle Neogenesis through the Receptor, Gpr44
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- The therapeutic potential of CRTH2/DP2 beyond allergy and asthma
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Divergent proliferation patterns of distinct human hair follicle epithelial progenitor niches in situ and their differential responsiveness to prostaglandin D2
- Experimental and early investigational drugs for androgenetic alopecia
- Current issues on the genetic implications and treatment of androgenic alopecia
- Lifestyle factors affecting the pathogenesis of androgenetic alopecia: a literature review
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Recent Progress in Prostaglandin F<sub>2</sub><i><sub>α</sub></i>Ethanolamide (Prostamide F<sub>2</sub><i><sub>α</sub></i>) Research and Therapeutics
- Uncovering novel biomarkers and drug targets for androgenetic alopecia via metabolite regulation and multi-tissue validation
- Prostanoids and Hair Follicles: Implications for Therapy of Hair Disorders
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Computer-Aided Designing Peptide Inhibitors of Human Hematopoietic Prostaglandin D2 Synthase Combined Molecular Docking and Molecular Dynamics Simulation
- Selection signatures for fiber production in commercial species: A review
- Prostaglandins: Key players in immunomodulation of the nervous system
- Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials
- ENZYMES
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation